Stay updated on Nivolumab Combo in Advanced Biliary Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Combo in Advanced Biliary Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Combo in Advanced Biliary Cancer Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T22:40:34.000Z thumbnail image
  4. Check
    3 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage. This change likely represents an update or modification related to medical and healthcare publications or documentation, specifically concerning a study evaluating the effect of investigational drug nivolumab in combination with gemcitabine/cisplatin or ipilimumab for patients with advanced unresectable biliary tract cancer.
    Difference
    0.1%
    Check dated 2024-06-06T14:47:59.000Z thumbnail image
  7. Check
    24 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for patients with biliary tract adenocarcinoma, specifying inclusion and exclusion criteria for the study. This change provides more specific information about the health conditions and prior treatments required for participation in the clinical trial.
    Difference
    40%
    Check dated 2024-05-22T21:30:53.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T22:49:23.000Z thumbnail image

Stay in the know with updates to Nivolumab Combo in Advanced Biliary Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Combo in Advanced Biliary Cancer Clinical Trial page.